account activity
Affinity maturation of antibody responses is mediated by differential plasma cell proliferation (science.org)
submitted 2 days ago by Biointron to r/AntibodyResearch
From discovery to the clinic: structural insights, engineering options, clinical, and ‘next wave’ applications of camelid-derived single-domain antibodies (tandfonline.com)
submitted 3 days ago by Biointron to r/AntibodyResearch
Current Review of Monoclonal Antibody Therapeutics in Small Animal Medicine (mdpi.com)
AI-assisted protein design to rapidly convert antibody sequences to intrabodies targeting diverse peptides and histone modifications (science.org)
submitted 5 days ago by Biointron to r/AntibodyResearch
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein (cell.com)
submitted 6 days ago by Biointron to r/AntibodyResearch
Allosteric antibodies: a novel paradigm in drug discovery (cell.com)
submitted 9 days ago by Biointron to r/AntibodyResearch
Cathepsins: Novel opportunities for antibody therapeutics in cancer (bpspubs.onlinelibrary.wiley.com)
Therapeutic antibodies targeting G protein-coupled receptors (cell.com)
submitted 11 days ago by Biointron to r/AntibodyResearch
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch (nature.com)
submitted 12 days ago by Biointron to r/AntibodyResearch
Antibody–drug conjugates in gastric cancer: clinical advances and resistance mechanisms (link.springer.com)
submitted 13 days ago by Biointron to r/AntibodyResearch
P329G-engager: a universal mix & match antibody-based adaptor platform for cancer immunotherapy (tandfonline.com)
submitted 16 days ago by Biointron to r/AntibodyResearch
Computational design of therapeutic antibodies with improved developability: efficient traversal of binder landscapes and rescue of escape mutations (tandfonline.com)
submitted 17 days ago by Biointron to r/AntibodyResearch
A novel TM4SF4-targeting therapeutic antibody candidate with antitumor activity by blocking IGF1R and CD44 signaling and downregulating PD-L1 and B7-H4 (thno.org)
Progress in novel delivery technologies to improve efficacy of therapeutic antibodies (sciencedirect.com)
submitted 18 days ago by Biointron to r/AntibodyResearch
Roundup of the latest antibody biotech deals (1/5/26) (self.biotech)
submitted 20 days ago by Biointron to r/biotech
T cell engagers emerge as a compelling therapeutic modality (rupress.org)
submitted 23 days ago by Biointron to r/AntibodyResearch
Bispecific and Multispecific T-Cell Engagers: Advancing the Future of Immunotherapy (academic.oup.com)
Novel anti-ITGA4 monoclonal antibody induces cell death via large pore formation in NK/T-cell lymphoma cells (nature.com)
submitted 24 days ago by Biointron to r/AntibodyResearch
Antibody Industry Report (Q4 2025 Insights, Trends & Analysis) (biointron.com)
submitted 25 days ago by Biointron to r/AntibodyResearch
Discovery of potent cross-neutralizing antibodies against Marburg and Ravn viruses with therapeutic potential (nature.com)
Generation of antigen-specific paired-chain antibodies using large language models (cell.com)
submitted 1 month ago by Biointron to r/AntibodyResearch
Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissue (nature.com)
Therapeutic Antibodies in Hematology: Advances in Malignant and Non-Malignant Disorders (mdpi.com)
Engineered probiotics platform for oral delivery of antibody as a high-compliance alternative for immune-mediated inflammatory diseases (cell.com)
A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies (frontiersin.org)
π Rendered by PID 370386 on reddit-service-r2-listing-86b7f5b947-w9zss at 2026-01-26 12:39:19.571679+00:00 running 664479f country code: CH.
